Drug Discovery and Development

    About       Membership     Newsfeed        Events           Shared Core Network       Training & Resources  Funding Opportunities

 

Innovative Drug Discovery and Development


Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.


News:

Fannin Innovation Studio is Hiring!

Artificial Intelligence Shakes Up Drug Discovery
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.


Thank you to everyone who helped make our Kickoff Mini-Symposium a success! For speaker and panel videos, Click Here.


Upcoming Events:

SBIR/STTR Workshop, October 3, 2019
The GCC Innovative Drug Discovery and Development Consortia will host this 8 hour SBIR/STTR workshop in place of their monthly round-table series.  Presented by Eva Garland Consulting. All participants will be will be provided with copies of the book ” Winning NIH SBIR/STTR Grants: A Ten Week Plan for Preparing your Phase I Application ” and “Winning NIH SBIR/STTR Grants: A Twelve Week Plan for Preparing your Phase II Application” as well as electronic and hard copies of the slide deck and other training materials used during the workshop. The subsidized cost to attend is $125 (includes all materials, breakfast, lunch, and parking) and seating is limited to 45, so be sure and register early. 
Registration.

ADME: Lead Characterization and Optimization, October 29, 2019
We invite you to REGISTER for this exciting conference introducing our newest CPRIT-funded GCC Center for PK/PD and Formulation (CCPF). Topics discussed will include protein:protein interactions, biologics, small molecules and examples of projects from users of the core.  Confirmed speakers include S.W. Johnny Lau, FDA; Fadi Ibrahim, Pfizer; Oscar Ekpenyong, Merck; Cinzia Stella, Genetech; Mark Cox, UT El Paso; Dong Liang, TSU; Diana Chow, UH; Huan Xie, TSU; Robert Tsai, IBT; and Stan Watowich, UTMB.
Conference Website

IDDD Round Table Workshop on Emerging Screening Technologies for Drug Discovery, November 7, 2019
Confirmed speakers include Lisa Marcaurelle, Director of Chemistry at GlaxoSmithKline and Damian Young, Baylor College of Medicine.  When you register, you will have the opportunity to submit questions that you would like for the speakers to address during the interactive round-table discussion that will follow their presentations. 
Registration will be limited to 70.
Registration.

Save the Date:
2
nd Annual Innovative Drug Discovery and Development Conference, May 11-12, 2020
Please save the date for this exciting conference and stay tuned for speaker updates.  James Inglese, NIH/NCATS is confirmed.